Abstract
Background
Methods
Results
Conclusion
Keywords
- •Human exposure to oil spill and dispersant use has a potential to alter both hematological and hepatic profiles.
- •The hematological and hepatic alterations include decreased platelets and BUN, and increased creatinine, serum levels of ALP, AST, and ALT.
- •The most reported somatic symptoms are headache, shortness of breath, skin rash, cough, fatigue, painful joints, and chest pain.
Repanich J. The Deepwater Horizon spill by the numbers. Available at: http://www.popularmechanics.com/science/energy/coal-oil-gas/bp-oil-spill-statistics. Accessed May 22, 2013.
Repanich J. The Deepwater Horizon spill by the numbers. Available at: http://www.popularmechanics.com/science/energy/coal-oil-gas/bp-oil-spill-statistics. Accessed May 22, 2013.
Sandler DP, Kwok RK, Engel LS, Parks C, London SJ, Miller AK. GuLF Study: gulf long-term follow-up study. Available at: http://www.niehs.nih.gov/research/programs/gulfspill/gulfstudy/backgrounddocuments/gulf_study_protocol_7092012.pdf. Accessed May 22, 2013.

Materials and Methods
Subjects
Chart Review and Evaluation
Statistics
Results
Demographics | Unexposed | Exposed | P Value |
---|---|---|---|
Total subjects | 130 (100%) | 117 (100%) | - |
Sex | .000 | ||
Male | 43 (33%) | 104 (89%) | |
Female | 87 (67%) | 13 (11%) | |
Age, years | .000 | ||
Mean | 49.8 | 35.8 | |
Median | 51 | 34 | |
Range | 15-90 | 18-63 | |
Age group, years | .000 | ||
<20 | 4 (3%) | 0 (0%) | |
≥20-<30 | 13 (10%) | 31 (27%) | |
≥30-<40 | 12 (9%) | 42 (36%) | |
≥40-<50 | 28 (22%) | 35 (30%) | |
≥50-<60 | 41 (32%) | 8 (7%) | |
≥60-<70 | 20 (15%) | 1 (1%) | |
≥70 | 12 (9%) | 0 (0%) |
Variable | Unexposed (n = 130) | Exposed (n = 117) | P Value |
---|---|---|---|
WBC (× 103 per μL) | 6.5 ± 1.9 | 6.9 ± 1.9 | .108 |
Platelets (× 103 per μL) | 269.6 ± 77.3 | 252.1 ± 51.8 | .024 |
Hemoglobin (g per dL) | 13.6 ± 1.6 | 14.9 ± 1.3 | .000 |
Hematocrit (%) | 40.8 ± 5.0 | 44.6 ± 3.4 | .000 |
BUN (mg per dL) | 15.4 ± 7.1 | 13.4 ± 3.4 | .014 |
Creatinine (mg per dL) | 0.9 ± 0.3 | 1.0 ± 0.2 | .000 |
ALP (IU per L) | 61.2 ± 26.9 | 76.3 ± 21.3 | .000 |
AST (IU per L) | 22.8 ± 15.1 | 31.0 ± 26.3 | .004 |
ALT (IU per L) | 29.8 ± 27.0 | 34.8 ± 26.6 | .054 |
Variable | Age Group | Unexposed | Exposed | P Value |
---|---|---|---|---|
WBC (× 103 per μL) | <40 years | 6.5 ± 1.9 | 6.6 ± 1.7 | .461 |
≥40 years | 6.5 ± 1.9 | 7.5 ± 2.0 | .007 | |
Platelets (× 103 per μL) | <40 years | 283.6 ± 67.3 | 251.8 ± 51.7 | .006 |
≥40 years | 249.5 ± 60.7 | 252.5 ± 52.4 | .134 | |
Hemoglobin (g per dL) | <40 years | 13.7 ± 1.8 | 14.9 ± 1.3 | .000 |
≤40 years | 13.6 ± 1.6 | 14.9 ± 1.4 | .000 | |
Hematocrit (%) | ≥40 years | 40.2 ± 5.9 | 44.7 ± 3.4 | .000 |
≥40 years | 41.0 ± 4.8 | 44.4 ± 3.4 | .000 | |
BUN (mg per dL) | <40 years | 12.1 ± 3.8 | 13.6 ± 3.3 | .039 |
≥40 years | 15.7 ± 5.6 | 14.5 ± 2.8 | .389 | |
Creatinine (mg per dL) | <40 years | 0.8 ± 0.2 | 1.1 ± 0.2 | .000 |
≥40 years | 0.9 ± 0.3 | 1.0 ± 0.2 | .044 | |
ALP (IU per L) | <40 years | 65.0 ± 21.7 | 74.9 ± 20.9 | .026 |
≥40 years | 67.5 ± 20.2 | 78.6 ± 22.0 | .001 | |
AST (IU per L) | <40 years | 20.9 ± 6.2 | 31.6 ± 9.0 | .050 |
≥40 years | 23.5 ± 4.7 | 30.0 ± 5.8 | .048 | |
ALT (IU per L) | <40 years | 22.9 ± 12.5 | 33.8 ± 22.9 | .050 |
≥40 years | 26.0 ± 13.8 | 40.1 ± 20.7 | .054 |
Variable | Sex | Unexposed | Exposed | P Value |
---|---|---|---|---|
WBC (× 103 per μL) | Male | 6.7 ± 2.2 | 6.8 ± 1.8 | .343 |
Female | 6.4 ± 1.7 | 7.5 ± 2.2 | .022 | |
Platelets (× 103 per μL) | Male | 234.6 ± 71.5 | 248.7 ± 52.0 | .094 |
Female | 287.0 ± 74.5 | 278.7 ± 42.5 | .348 | |
Hemoglobin (g per dL) | Male | 14.6± 1.5 | 15.1 ± 1.3 | .022 |
Female | 13.1 ± 1.5 | 13.3 ± 0.9 | .331 | |
Hematocrit (%) | Male | 42.9 ± 5.4 | 45.1 ± 3.2 | .000 |
Female | 39.8 ± 4.5 | 40.5 ± 2.3 | .293 | |
BUN (mg per dL) | Male | 17.7 ± 9.3 | 13.4 ± 3.4 | .000 |
Female | 14.1 ± 5.1 | 13.0 ± 3.6 | .228 | |
Creatinine (mg per dL) | Male | 1.1 ± 0.3 | 1.1 ± 0.2 | .381 |
Female | 0.8 ± 0.2 | 0.8 ± 0.2 | .202 | |
ALP (IU per L) | Male | 64.3 ± 18.0 | 76.9 ± 21.0 | .018 |
Female | 62.2 ± 16.1 | 71.3 ± 23.1 | .048 | |
AST (IU per L) | Male | 21.6 ± 6.8 | 32.7 ± 7.5 | .051 |
Female | 18.6 ± 7.3 | 20.7 ± 5.0 | .046 | |
ALT (IU per L) | Male | 27.4 ± 13.5 | 38.2 ± 27.0 | .054 |
Female | 17.6 ± 12.0 | 26.1 ± 24.6 | .039 |
Variable | Age Group 20-29 Years (n = 31) | Age Group 30-39 Years (n = 42) | Age Over 40 Years (n = 44) | P Value | P Value | P Value |
---|---|---|---|---|---|---|
WBC (× 103 per μL) | 6.2 ± 1.6 | 6.8 ± 1.8 | 7.5 ± 2.0 | .02 | .001 | .08 |
Hemoglobin (g per dL) | 15.0 ± 1.3 | 14.8 ± 1.3 | 14.9 ± 1.4 | .5 | .3 | .3 |
Hematocrit (%) | 45.0 ± 3.5 | 44.4 ± 3.3 | 44.4 ± 3.4 | .5 | .2 | .5 |
Platelets (× 103 per μL) | 245.2 ± 50.1 | 256.6 ± 55.8 | 252.5 ± 52.9 | .1 | .3 | .4 |
BUN (mg per dL) | 13.1 ± 3.2 | 13.4 ± 3.7 | 13.7 ± 3.3 | .1 | .2 | .5 |
Creatinine (mg per dL) | 1.0 ± 0.2 | 1.1 ± 0.2 | 0.97 ± 0.2 | .03 | .2 | .00 |
β-2-microglobulin (mg per L) | 76.1 ± 21.4 | 74.1 ± 20.5 | 78.6 ± 22.1 | .3 | .3 | .1 |
ALP (IU per L) | 29.1 ± 29.0 | 33.4 ± 31 | 30.0 ± 21.4 | .4 | .4 | .4 |
AST (IU per L) | 32.7 ± 32.1 | 34.5 ± 18.5 | 37.6 ± 29.9 | .5 | .3 | .2 |
ALT (IU per L) | 1.3 ± 0.3 | 1.3 ± 0.4 | 1.4 ± 0.3 | .5 | .02 | .05 |
Urinary Phenol (mg per L) | 8.7 ± 9.5 | 7.6 ± 9.9 | 5.3 ± 5.9 | .47 | .03 | .09 |

Variable | Male (n = 104) | Female (n = 13) |
---|---|---|
Headaches | 78 (75%) | 12 (92%) |
Shortness of breath | 74 (71%) | 9 (69%) |
Skin rash | 63 (61%) | 6 (46%) |
Chronic cough | 57 (55%) | 3 (23%) |
Fatigue | 50 (48%) | 8 (62%) |
Painful joints | 48 (46%) | 9 (69%) |
Chest pain | 40 (38%) | 4 (31%) |
Night sweats | 40 (38%) | 8 (62%) |
Heartburn | 33 (32%) | 5 (38%) |
Ringing in ears | 33 (32%) | 9 (69%) |
Diarrhea | 27 (26%) | 5 (38%) |
Poor appetite | 27 (26%) | 1 (8%) |
Memory loss | 21 (20%) | 6 (46%) |
Symptoms | Age Group 20-29 Years (n = 31) | Age Group 30-39 Years (n = 42) | Age Over 40 Years (n = 44) |
---|---|---|---|
Headaches | 25 (81%) | 33 (79%) | 32 (73%) |
Painful joints | 20 (65%) | 16 (38%) | 21 (48%) |
Skin rash | 19 (61%) | 23 (55%) | 27 (61%) |
Shortness of breath | 18 (58%) | 34 (81%) | 31 (70%) |
Night sweats | 16 (52%) | 15 (36%) | 17 (39%) |
Fatigue | 15 (48% ) | 20 (48%) | 23 (52%) |
Dizzy spells | 15 (48%) | 24 (57%) | 21 (48%) |
Chest pain | 13 (42%) | 20 (48%) | 11 (25%) |
Chronic cough | 12 (39%) | 22 (52%) | 26 (59%) |
Heartburn | 11(35%) | 13 (31%) | 14 (32%) |
Ringing in ears | 11(35%) | 13 (31%) | 18 (41%) |
Poor appetite | 8 (26%) | 11 (26%) | 9 (20%) |
Memory loss | 8 (26%) | 5 (12%) | 14 (32%) |
Diarrhea | 7 (23%) | 13 (31%) | 12 (27%) |
Discussion
Study Limitations
Conclusion
Acknowledgment
References
- A comparison of the efficiency of different surfactants for removal of crude oil from contaminated soils.Chemosphere. 2006; 62: 1403-1410
- Health effects of the Gulf oil spill.JAMA. 2010; 304: 1118-1119
- Gulf Coast oil disaster: impact on human reproduction.Fertil Steril. 2010; 94: 1575-1577
- The Gulf oil spill.N Engl J Med. 2011; 364: 1334-1348
- The legacy of the Gulf oil spill: analyzing acute public health effects and predicting chronic ones in Louisiana.Am J Disaster Med. 2011; 6: 5-22
- Acute health effects of the Sea Empress oil spill.J Epidemiol Community Health. 1999; 53: 306-310
- Hebei spirit oil spill exposure and subjective symptoms in residents participating in clean-up activities.Environ Health Toxicol. 2011; 26: e2011007
- Association between health information, use of protective devices and occurrence of acute health problems in the Prestige oil spill clean-up in Asturias and Cantabria (Spain): a cross-sectional study.BMC Public Health. 2006; 6: 1
- Tasman spirit oil spill in Pakistan: Research response and lessons learned.Am J Ind Med. 2012; 56: 124-131
- The Exxon Valdez and BP oil spills: a comparison of initial social and psychological impacts.Am Behav Sci. 2012; 56: 3-23
Repanich J. The Deepwater Horizon spill by the numbers. Available at: http://www.popularmechanics.com/science/energy/coal-oil-gas/bp-oil-spill-statistics. Accessed May 22, 2013.
- Is using dispersants on the BP Gulf oil spill fighting pollution with pollution?.Sci Am. 2010;June; 18: 22
Sandler DP, Kwok RK, Engel LS, Parks C, London SJ, Miller AK. GuLF Study: gulf long-term follow-up study. Available at: http://www.niehs.nih.gov/research/programs/gulfspill/gulfstudy/backgrounddocuments/gulf_study_protocol_7092012.pdf. Accessed May 22, 2013.
- Review on the effects of exposure to spilled oils on human health.J Appl Toxicol. 2010; 30: 291-301
- Exposure to oil spill has detrimental effect on clean-up workers' health.Lancet. 2003; 361: 147
- The effects of the gulf oil spill on children.J Spec Pediatr Nurs. 2011; 16: 70-74
- Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case-control study.Am J Ind Med. 2008; 51: 803-811
- Hematopoietic malignancies and related disorders among benzene-exposed workers in China.Leuk Lymphoma. 1994; 14: 91-102
- Benzene and lymphohematopoietic malignancies in China.J Toxicol Environ Health A. 2000; 61: 419-432
- Lymphohaematopoietic cancer risk among chemical workers exposed to benzene.Occup Environ Med. 2004; 61: 270-274
- Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis.Environ Health. 2010; 9: 31
- Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.Carcinogenesis. 2012; 33: 240-252
- Gulf oil spill. Ten months after Deepwater Horizon, picking up the remnants of health data.Science. 2011; 331: 1252
- Effects of phosphorothionate on the reproductive system of male rats.J Environ Sci Health Part B. 2001; 36: 445-456
- Study of some biochemical changes among workers occupationally exposed to phenol, alone or in combination with other organic solvents.Ind Health. 1994; 32: 207-214
- Effect of Benzene on liver functions in rats (Rattus norvegicus).Environ Monit Assess. 2009; 154: 23-27
- A study on the acute toxicological effect of commercial diesel fuel in Nigeria in rats (Ratus ratus) using hematological parameters.J Appl Sci Environ Manage. 2002; 6: 84-86
- The origin of elevation of serum alkaline phosphatase in hepatic disease. An experimental study.Gastroenterology. 1962; 42: 431-438
- Source of the elevated serum alkaline phosphatase activity in biliary obstruction: studies utilizing isolated liver perfusion.Gastroenterology. 1964; 47: 166-170
- Phenol excretion as a measure of benzene exposure.Ann Occup Hyg. 1967; 10: 317-326
- Quantitative relation of urinary phenol levels to breathzone benzene concentrations: a factory survey.Br J Ind Med. 1986; 43: 692-697
- Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia.Leukemia. 2001; 15: 10-20
- Acute health problems among the people engaged in the cleanup of the Nakhodka oil spill.Environ Res. 1999; 81: 185-194
Article info
Publication history
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: Both authors listed in the manuscript had access to the data and a role in preparing the manuscript.
Identification
Copyright
ScienceDirect
Access this article on ScienceDirectLinked Article
- Study Methodology Prevents Interpretation of Findings in Workers Involved in Gulf Oil Spill Cleanup ActivitiesThe American Journal of MedicineVol. 127Issue 9
- PreviewWe read with interest a recent report by D'Andrea and Reddy1 describing differences in hematologic and hepatic blood profiles among a cohort of workers involved in Gulf oil spill cleanup activities relative to an unexposed cohort. They report that cleanup workers had lower average levels of platelets, blood urea nitrogen, and creatinine, and higher levels of hemoglobin, hematocrit, alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase. The authors also postulate that “the oil spill exposure appears to play a role in the development of hematologic and hepatic toxicity.” The relation of these findings to exposures associated with cleanup activities cannot be interpreted given the current study design, lack of exposure history, and laboratory analysis.
- Full-Text
- Preview
- Major Concerns About Study Design and Clinical Biomarker InterpretationThe American Journal of MedicineVol. 127Issue 9
- PreviewWe are writing this letter in response to the recent article in The American Journal of Medicine by D'Andrea and Reddy.1 Our primary concerns are with their convenience sampling and case-control mismatching, and the authors' conclusions about the clinical results. The clinical results indicate that both groups in their study, unexposed and exposed, have clinical biomarker values for both liver function and blood profiles that essentially fall within the normal ranges for healthy adult individuals (Table).
- Full-Text
- Preview